(VSH) Vishay Intertechnology - Overview
Stock: Semiconductors, Resistors, Capacitors, Inductors, Optoelectronics
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.57% |
| Yield on Cost 5y | 1.82% |
| Yield CAGR 5y | 0.96% |
| Payout Consistency | 39.4% |
| Payout Ratio | 13.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 43.0% |
| Relative Tail Risk | -5.18% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.49 |
| Alpha | -16.34 |
| Character TTM | |
|---|---|
| Beta | 2.103 |
| Beta Downside | 2.207 |
| Drawdowns 3y | |
|---|---|
| Max DD | 63.55% |
| CAGR/Max DD | 0.01 |
Description: VSH Vishay Intertechnology January 14, 2026
Vishay Intertechnology (NYSE:VSH) designs, manufactures, and distributes a broad portfolio of discrete semiconductors and passive components-including MOSFETs, diodes, optoelectronics, resistors, inductors, and capacitors-across six operating segments. The company serves a diversified set of end markets such as industrial, automotive (including electric-vehicle powertrains), telecommunications, computing, consumer electronics, military/aerospace, and medical devices, with manufacturing footprints in the U.S., Europe, Israel, and Asia.
Key quantitative signals (as of FY 2023) show total revenue of roughly $3.5 billion, an operating margin near 15 %, and a cash conversion cycle of about 45 days, indicating solid cash generation despite cyclical demand. The MOSFET segment, which benefits from rising EV adoption and data-center power-conversion needs, grew at an estimated 12 % YoY, while the optoelectronic line is expanding modestly (~5 % YoY) driven by increased demand for IR sensors in automotive driver-assistance systems. Sector-wide, the electronic-components market is sensitive to global chip-fab capacity constraints and macro-economic cycles in automotive and consumer spending, which introduces upside volatility but also a structural tailwind from the ongoing electrification and digitalization trends.
If you want a deeper, data-driven breakdown of Vishay’s financials and scenario analysis, the ValueRay platform provides the granular metrics needed to assess the upside potential and risk profile.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: -8.98m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA 1.46 > 1.0 |
| NWC/Revenue: 38.02% < 20% (prev 41.09%; Δ -3.07% < -1%) |
| CFO/TA 0.04 > 3% & CFO 184.3m > Net Income -8.98m |
| Net Debt (654.1m) to EBITDA (288.9m): 2.26 < 3 |
| Current Ratio: 2.62 > 1.5 & < 3 |
| Outstanding Shares: last quarter (136.7m) vs 12m ago 0.50% < -2% |
| Gross Margin: 19.38% > 18% (prev 0.21%; Δ 1917 % > 0.5%) |
| Asset Turnover: 73.56% > 50% (prev 71.46%; Δ 2.09% > 0%) |
| Interest Coverage Ratio: 1.66 > 6 (EBITDA TTM 288.9m / Interest Expense TTM 38.7m) |
Altman Z'' 3.08
| A: 0.28 (Total Current Assets 1.89b - Total Current Liabilities 720.4m) / Total Assets 4.23b |
| B: 0.21 (Retained Earnings 892.2m / Total Assets 4.23b) |
| C: 0.02 (EBIT TTM 64.2m / Avg Total Assets 4.17b) |
| D: 0.46 (Book Value of Equity 987.2m / Total Liabilities 2.15b) |
| Altman-Z'' Score: 3.08 = A |
Beneish M -3.02
| DSRI: 0.91 (Receivables 381.8m/401.9m, Revenue 3.07b/2.94b) |
| GMI: 1.10 (GM 19.38% / 21.32%) |
| AQI: 1.01 (AQ_t 0.13 / AQ_t-1 0.13) |
| SGI: 1.04 (Revenue 3.07b / 2.94b) |
| TATA: -0.05 (NI -8.98m - CFO 184.3m) / TA 4.23b) |
| Beneish M-Score: -3.02 (Cap -4..+1) = AA |
What is the price of VSH shares?
Over the past week, the price has changed by -0.99%, over one month by +20.47%, over three months by +37.81% and over the past year by +16.50%.
Is VSH a buy, sell or hold?
- StrongBuy: 2
- Buy: 0
- Hold: 1
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the VSH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 18 | -9.8% |
| Analysts Target Price | 18 | -9.8% |
| ValueRay Target Price | 22.4 | 12.5% |
VSH Fundamental Data Overview February 07, 2026
P/S = 0.8681
P/B = 1.2895
P/EG = 0.75
Revenue TTM = 3.07b USD
EBIT TTM = 64.2m USD
EBITDA TTM = 288.9m USD
Long Term Debt = 919.7m USD (from longTermDebt, two quarters ago)
Short Term Debt = 26.5m USD (from shortTermDebt, last quarter)
Debt = 1.17b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 654.1m USD (from netDebt column, last quarter)
Enterprise Value = 3.32b USD (2.66b + Debt 1.17b - CCE 515.2m)
Interest Coverage Ratio = 1.66 (Ebit TTM 64.2m / Interest Expense TTM 38.7m)
EV/FCF = -37.29x (Enterprise Value 3.32b / FCF TTM -89.0m)
FCF Yield = -2.68% (FCF TTM -89.0m / Enterprise Value 3.32b)
FCF Margin = -2.90% (FCF TTM -89.0m / Revenue TTM 3.07b)
Net Margin = -0.29% (Net Income TTM -8.98m / Revenue TTM 3.07b)
Gross Margin = 19.38% ((Revenue TTM 3.07b - Cost of Revenue TTM 2.47b) / Revenue TTM)
Gross Margin QoQ = 19.58% (prev 19.46%)
Tobins Q-Ratio = 0.78 (Enterprise Value 3.32b / Total Assets 4.23b)
Interest Expense / Debt = 0.83% (Interest Expense 9.75m / Debt 1.17b)
Taxrate = 21.0% (US default 21%)
NOPAT = 50.7m (EBIT 64.2m * (1 - 21.00%))
Current Ratio = 2.62 (Total Current Assets 1.89b / Total Current Liabilities 720.4m)
Debt / Equity = 0.56 (Debt 1.17b / totalStockholderEquity, last quarter 2.09b)
Debt / EBITDA = 2.26 (Net Debt 654.1m / EBITDA 288.9m)
Debt / FCF = -7.35 (negative FCF - burning cash) (Net Debt 654.1m / FCF TTM -89.0m)
Total Stockholder Equity = 2.07b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.22% (Net Income -8.98m / Total Assets 4.23b)
RoE = -0.43% (Net Income TTM -8.98m / Total Stockholder Equity 2.07b)
RoCE = 2.14% (EBIT 64.2m / Capital Employed (Equity 2.07b + L.T.Debt 919.7m))
RoIC = 1.68% (NOPAT 50.7m / Invested Capital 3.01b)
WACC = 9.70% (E(2.66b)/V(3.83b) * Re(13.67%) + D(1.17b)/V(3.83b) * Rd(0.83%) * (1-Tc(0.21)))
Discount Rate = 13.67% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.91%
Fair Price DCF = unknown (Cash Flow -89.0m)
EPS Correlation: -87.10 | EPS CAGR: -67.91% | SUE: -0.05 | # QB: 0
Revenue Correlation: -72.68 | Revenue CAGR: -1.69% | SUE: 1.07 | # QB: 2
EPS next Quarter (2026-03-31): EPS=0.02 | Chg30d=-0.087 | Revisions Net=+1 | Analysts=1
EPS current Year (2026-12-31): EPS=0.38 | Chg30d=-0.362 | Revisions Net=+1 | Growth EPS=+861.8% | Growth Revenue=+9.3%
EPS next Year (2027-12-31): EPS=0.95 | Chg30d=N/A | Revisions Net=+0 | Growth EPS=+149.4% | Growth Revenue=+8.3%